Pituitary disorders in patients with end-stage chronic renal failure
Problems of Endocrinology · 2024
DOI: 10.14341/probl13212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Endocrinology, 2024. Verfasst von T N Markova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov; City Clinical Hospital №52. Hauptthemen laut MEDLINE: Human Growth Hormone, Pituitary Diseases, Kidney Failure, Chronic, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Disorders in the kidneys lead to disturbance of homeostasis. As the glomerular filtration rate decreases, the metabolism of numerous biologically active substances, including pituitary hormones, decreases. The article presents an overview of pituitary dysfunction in patients with chronic kidney disease (CKD) and discusses the possible reasons of the pathogenetic mechanisms. Particular focus is being given to the assessment of changes in the concentration of pituitary hormones in patients with end-stage chronic kidney disease (CKD) and discusses the pathogenetic mechanisms of their formation. Particular attention is paid to the assessment of changes in the concentration of pituitary hormones in patients receiving renal replacement therapy (RRT). CKD leads to an increase in the level of prolactin, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Concentrations of growth hormone (GH), isulin-like growth factor-1 (IGF-1), thyroid-stimulating hormone (TSH), adrenocorticotropic hormone (ACTH) and vasopressin may remain within normal values or increase in this group of patients. RRT does not reduce the levels of prolactin, LH, FSH, while the concentration of growth hormone, IGF-1, TSH tends to normalize. The content of ACTH and vasopressin may remain unchanged or decrease. Kidney transplantation in most cases corrects hormonal disorders. Correction of hormonal changes can improve the clinical outcome and quality of life of patients with end stage CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov; City Clinical Hospital №52.
- Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov.
- Medical Center «Med Garant».
Zitieren
APA
Markova, T. N., Kosova, E. V., & Mishchenko, N. K. (2024). Pituitary disorders in patients with end-stage chronic renal failure. Problems of Endocrinology. https://doi.org/10.14341/probl13212
Vancouver
Markova TN, Kosova EV, Mishchenko NK. Pituitary disorders in patients with end-stage chronic renal failure. Problems of Endocrinology. 2024. doi:10.14341/probl13212
BibTeX
@article{Markova2024,
author = {Markova, T N and Kosova, E V and Mishchenko, N K},
title = {Pituitary disorders in patients with end-stage chronic renal failure},
journal = {Problems of Endocrinology},
year = {2024},
doi = {10.14341/probl13212}
}
EUVIMED